Rimantadine
- Generic Name
- Rimantadine
- Drug Type
- Small Molecule
- Chemical Formula
- C12H21N
- CAS Number
- 13392-28-4
- Unique Ingredient Identifier
- 0T2EF4JQTU
Overview
An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Background
An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Indication
For the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults.
Associated Conditions
- Influenza A Virus Infection
Clinical Trials
FDA Approved Products
Rimantadine Hydrochloride
Manufacturer:H.J. Harkins Company, Inc.
Route:ORAL
Strength:100 mg in 1 1
Approved: 2011/09/12
NDC:52959-305
Rimantadine Hydrochloride
Manufacturer:STAT Rx USA LLC
Route:ORAL
Strength:100 mg in 1 1
Approved: 2012/08/14
NDC:16590-202
Rimantadine Hydrochloride
Manufacturer:Carilion Materials Management
Route:ORAL
Strength:100 mg in 1 1
Approved: 2010/05/17
NDC:68151-2103
Rimantadine Hydrochloride
Manufacturer:Amneal Pharmaceuticals of New York LLC
Route:ORAL
Strength:100 mg in 1 1
Approved: 2023/12/31
NDC:0115-1911
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath